Skip to content

207.878.2770mail@immucell.com

Immucell

Immediate Immunity™

About ImmuCell
First Defense
Re-Tain
- Re-Tain™ for Mastitis
- CMT for Mastitis
Sales & Distributors
Resources
News
Investors

About ImmuCell
First Defense
Re-Tain
- Re-Tain™ for Mastitis
- CMT for Mastitis
Sales & Distributors
Resources
News
Investors

Events & Presentations

COMPANY CONTACT

Michael F. Brigham
President & CEO
mail@immucell.com
207.878.2770

INVESTOR CONTACT

Lytham Partners, LLC
iccc@lythampartners.com
602.889.9700

Events & Presentations

Contact Us

56 Evergreen Drive
Portland, ME 04103

Office: 207.878.2770

Sales: 1.800.IMMUCELL

mail@immucell.com

NASDAQ: ICCC

Privacy Policy
Terms of Use

Recent News

02-21-23 ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022

02-15-23 ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022

01-09-23 ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022

Follow Us

Find us on:

Facebook page opens in new window YouTube page opens in new window

Copyright © 2020 ImmuCell Corporation

Home
About ImmuCell
First Defense
Re-Tain
Sales & Distributors
Resources
News
Investors
Contact Us

Footer Menu